Skip to content

The Effect of High-Flow Nasal Cannula Oxygen Therapy on Pulmonary Function in Patients After Scoliosis Correction Surgery: A Single-Center, Prospective, Randomized Controlled Study

The Effect of High-Flow Nasal Cannula Oxygen Therapy on Pulmonary Function in Patients After Scoliosis Correction Surgery: A Single-Center, Prospective, Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111253
Enrollment
Unknown
Registered
2025-10-28
Start date
2024-05-20
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Interventions

HFNC group: Immediate post-extubation administration of 2 hours of high-flow nasal oxygen therapy.
Standard facemask oxygen therapy group:The patient will receive mask oxygen therapy for 2 hours in the same environment.

Sponsors

Affiliated Drum Tower Hospital, Medical School of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The preoperative diagnosis was scoliosis; 2.The scoliosis was classified as thoracic or thoracolumbar curve. 3.ASA physical status classification: II~III; 4.The patient was scheduled for scoliosis correction surgery under general anesthesia. 5.The patient agreed to participate in this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Emergency surgery patients. 2.Patients undergoing non-primary spinal correction surgery. 3.Patients with unplanned endotracheal extubation after surgery. 4.Patients with severe cardiac, hepatic, or renal dysfunction. 5.Primary pulmonary diseases: bronchial asthma, pulmonary infections, etc. 6.Patients with severe visual/auditory dysfunction or communication barriers. 7.Patients with lumbosacral deformity only, without concomitant thoracic deformity.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;

Secondary

MeasureTime frame
Dyspnea score;Lung Ultrasound Score;Diaphragm thickness fraction (DTF);Pain Score(Visual Analog Scale);Pulmonary complications;Blood gas analysis;Comfort score(Visual Analog Scale);Vital signs data;Postoperative outpatient follow-up pulmonary function;

Countries

China

Contacts

Public ContactGu Xiaoping

Affiliated Drum Tower Hospital, Medical School of Nanjing University

xiaopinggu@nju.edu.cn+86 25 83106666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026